SlideShare a Scribd company logo
1 of 32
Download to read offline
COVID-19 variants and vaccines
Varsha Khodiyar, PhD
What is a virus?
Key virus facts
Source:https://www.open.edu/openlearn/science-maths-technology/biology/what-virus
● Genetic information (DNA or
RNA) surrounded by protein
● Different shapes and sizes,
typically 20–300 nm
● Cannot reproduce
independently, needs a host cell
● Can survive for only short
periods outside a host cell
The SARS-CoV-2 virus which causes the disease COVID-19
Image source: https://www.nsf.gov/discoveries/disc_summ.jsp?cntn_id=300334&org=NSF
Our cells also have RNA
Image source:
https://giphy.com/gifs/biology-primer-mRI1hW0ZBVUly
Image source:
https://www.ajconsultingcompany.com/cells_and_dna.html
What does the virus RNA do in our cells?
Image adapted from: https://courses.lumenlearning.com/boundless-biology/chapter/virus-infections-and-hosts/
SARS-CoV-2 attaches to
human cell using the
spike protein
SARS-CoV-2 virus
Human cell
● DNA and RNA are types of
genetic material
● RNA is a naturally
occurring part of our cells
How do new virus
strains evolve?
Changes to DNA or RNA can alter protein sequence
Image from: https://medlineplus.gov/genetics/understanding/mutationsanddisorders/possiblemutations/
Genetic material is routinely damaged,but usually repaired
Image adapted from: https://www.env.go.jp/en/chemi/rhm/basic-info/1st/03-02-03.html
Change caused by
chance or by
environment
(e.g. smoking)
RNA viruses do not have the same type of repair mechanism
and so are more likely to accumulate changes (mutations)
Image source: Proc Natl Acad Sci U S A 2010 doi: 10.1073/pnas.0906193106
Most changes will make the protein worse at doing its
job...
Image from: https://medlineplus.gov/genetics/understanding/mutationsanddisorders/possiblemutations/
...but by chance
some changes
may make the
protein better at
doing its job
Lots of changes results in new virus variants
Source: https://www.bbc.co.uk/news/health-55659820
● Changes to the genetic code
(mutations) happen all the time
● Most changes will make a protein
less effective
● Multiple changes can result in the
evolution of a new virus variant
What do we know
about the new
SARS-CoV-2 strains?
Research into SARS-CoV-2 and COVID-19 is ongoing
What we know so far
Sources: https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant.html ; https://www.bbc.co.uk/news/health-55659820
Identified variants are more transmissible,
i.e. easier to catch
Masks & social distancing work against these new variants
All variants recognized by existing vaccines
How do the coronavirus vaccines work?
Sources: https://wellcome.org/news/what-different-types-covid-19-vaccine-are-there
https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-vaccine/
Currently approved in the UK
Viral vector vaccine: Oxford-AstraZeneca
RNA vaccines: Pfizer-BioNTech, Moderna
Use the cell’s own protein making machinery to
make the virus protein
The viral protein triggers an immune response
The vaccines can be modified to recognise the new
strains
More about vaccines
Source: https://wellcome.org/news/what-different-types-covid-19-vaccine-are-there
Source: https://www.immunology.org/news/whats-in-vaccine
What do we mean by‘vaccine efficacy’?
Hypothetical efficacy of 80%
80 people in clinical trial protected against disease
20 people in clinical trial did not gain protection
against disease
Image adapted from: https://www.bmj.com/content/369/bmj.m1808
Reported efficacy against
original covid-19 strain
Oxford-AstraZeneca - 84%
Pfizer-BioNTech - 95%
Moderna - 92%
Source: https://www.who.int/
Poll -What is the effectiveness of the yearly flu vaccine?
0-20%
20-40%
40-60%
60-80%
Over 80% Flu vaccine image from www.shutterstock.com
40-60%
Effectiveness of the yearly influenza vaccines
(Reduction in risk of having to go to the doctor with flu)
Source: https://www.cdc.gov/flu/vaccines-work/effectiveness-studies.htm
SARS-CoV-2 will mutate
every time it replicates
We can reduce the chance for
new strains to evolve by
reducing the opportunities for
the virus to reproduce
COVID-19 is likely to become endemic
Source: https://www.nature.com/articles/d41586-021-00396-2
Finding out more
Image source:
https://mrbarlow.wordpress.com/2012/11/24/take-breaks-to-learn-more/
Use reputable news sources for latest information
Information sources I find useful:
BBC news website
BBC, ITV and Channel 4 TV news
programmes (radio & TV)
USA CDC website
(https://www.cdc.gov/coronavirus/2019-ncov/variants/index.html)
Nature news features
(https://www.nature.com/nature/articles?type=news-feature)
How can you tell if the information
is accurate?
Check multiple
sources
Debunking coronavirus myths -www.covidfaq.co
What is the difference between fact and opinion?
A fact is true, whether
or not you believe it
Can be proved to be
correct with evidence.
An opinion is what
someone thinks or
believes.
Cannot be proved to be
correct or incorrect.
Source: https://www.bbc.co.uk/teach/skillswise/fact-or-opinion/z4r7cqt
Check that your information
sources are reputable and
worthy of your trust
“Knowledge is power”
Sir Francis Bacon (1597)
@varsha_khodiyar
Varsha Khodiyar
The information in this slide deck was presented at
the Asha-Deep Project webinar
Thursday 18th February 2021
Asha-Deep Project email: ashadeepc19@gmail.com
Slide deck created by
Varsha Khodiyar
Slide deck licensed as CC-BY
https://creativecommons.org/licenses/by/4.0/

More Related Content

What's hot

COVID-19 (Coronavirus disease 2019) update
COVID-19 (Coronavirus disease 2019) updateCOVID-19 (Coronavirus disease 2019) update
COVID-19 (Coronavirus disease 2019) updateSun Yai-Cheng
 
Vaccine development for covid 19
Vaccine development for covid 19Vaccine development for covid 19
Vaccine development for covid 19SaptarshiDas78
 
Introduction to Vaccine Development in COVID-19
Introduction to Vaccine Development in COVID-19Introduction to Vaccine Development in COVID-19
Introduction to Vaccine Development in COVID-19Anahita Sharma
 
SARS-CoV-2 Variant of Concern Omicron
SARS-CoV-2 Variant of Concern OmicronSARS-CoV-2 Variant of Concern Omicron
SARS-CoV-2 Variant of Concern OmicronKULDEEP VYAS
 
Covid -19/ Sars-Cov-2
Covid -19/ Sars-Cov-2Covid -19/ Sars-Cov-2
Covid -19/ Sars-Cov-2Wazeed Basha
 
Cytokine release syndrome and Cytokine storm in COVID- 19 by Dr. Sonam Agga...
Cytokine release syndrome  and Cytokine storm in COVID- 19  by Dr. Sonam Agga...Cytokine release syndrome  and Cytokine storm in COVID- 19  by Dr. Sonam Agga...
Cytokine release syndrome and Cytokine storm in COVID- 19 by Dr. Sonam Agga...Dr. Sonam Aggarwal
 
Corona Virus Basic Introduction
Corona Virus Basic IntroductionCorona Virus Basic Introduction
Corona Virus Basic IntroductionShubham Kolge
 
Covid 19 pandemic (Coronavirus disease)
Covid 19 pandemic (Coronavirus disease)Covid 19 pandemic (Coronavirus disease)
Covid 19 pandemic (Coronavirus disease)Shalu Thariwal
 
The novel coronavirus disease 2019 (covid 19)overview
The novel  coronavirus disease 2019 (covid 19)overviewThe novel  coronavirus disease 2019 (covid 19)overview
The novel coronavirus disease 2019 (covid 19)overviewMakrani Shaharukh
 
Ppt COVID vaccination
Ppt COVID vaccinationPpt COVID vaccination
Ppt COVID vaccinationShinjan Patra
 
Covid 19 with cvs complications
Covid 19 with cvs complicationsCovid 19 with cvs complications
Covid 19 with cvs complicationsUmmay Sumaiya
 
Novel corona virus (COVID-19) its cause, symptoms and treatment
Novel corona virus (COVID-19) its cause, symptoms and treatmentNovel corona virus (COVID-19) its cause, symptoms and treatment
Novel corona virus (COVID-19) its cause, symptoms and treatmentMedical Knowledge
 
MOLECULAR TOOLS IN DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES
MOLECULAR TOOLS IN  DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES MOLECULAR TOOLS IN  DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES
MOLECULAR TOOLS IN DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES tawheedshafi
 

What's hot (20)

COVID-19 (Coronavirus disease 2019) update
COVID-19 (Coronavirus disease 2019) updateCOVID-19 (Coronavirus disease 2019) update
COVID-19 (Coronavirus disease 2019) update
 
Vaccine development for covid 19
Vaccine development for covid 19Vaccine development for covid 19
Vaccine development for covid 19
 
Introduction to Vaccine Development in COVID-19
Introduction to Vaccine Development in COVID-19Introduction to Vaccine Development in COVID-19
Introduction to Vaccine Development in COVID-19
 
COVID-19
COVID-19 COVID-19
COVID-19
 
Overview of COVID-19 vaccines: efficacy and priority group
Overview of COVID-19 vaccines: efficacy and priority groupOverview of COVID-19 vaccines: efficacy and priority group
Overview of COVID-19 vaccines: efficacy and priority group
 
SARS-CoV-2 Variant of Concern Omicron
SARS-CoV-2 Variant of Concern OmicronSARS-CoV-2 Variant of Concern Omicron
SARS-CoV-2 Variant of Concern Omicron
 
Covid -19/ Sars-Cov-2
Covid -19/ Sars-Cov-2Covid -19/ Sars-Cov-2
Covid -19/ Sars-Cov-2
 
Covid 19
Covid  19Covid  19
Covid 19
 
Cytokine release syndrome and Cytokine storm in COVID- 19 by Dr. Sonam Agga...
Cytokine release syndrome  and Cytokine storm in COVID- 19  by Dr. Sonam Agga...Cytokine release syndrome  and Cytokine storm in COVID- 19  by Dr. Sonam Agga...
Cytokine release syndrome and Cytokine storm in COVID- 19 by Dr. Sonam Agga...
 
Corona Virus Basic Introduction
Corona Virus Basic IntroductionCorona Virus Basic Introduction
Corona Virus Basic Introduction
 
Covid 19 a short briefing
Covid 19 a short briefingCovid 19 a short briefing
Covid 19 a short briefing
 
Covid 19
Covid 19Covid 19
Covid 19
 
Covid 19 pandemic (Coronavirus disease)
Covid 19 pandemic (Coronavirus disease)Covid 19 pandemic (Coronavirus disease)
Covid 19 pandemic (Coronavirus disease)
 
Corona virus
Corona virusCorona virus
Corona virus
 
The novel coronavirus disease 2019 (covid 19)overview
The novel  coronavirus disease 2019 (covid 19)overviewThe novel  coronavirus disease 2019 (covid 19)overview
The novel coronavirus disease 2019 (covid 19)overview
 
COVID-19
COVID-19COVID-19
COVID-19
 
Ppt COVID vaccination
Ppt COVID vaccinationPpt COVID vaccination
Ppt COVID vaccination
 
Covid 19 with cvs complications
Covid 19 with cvs complicationsCovid 19 with cvs complications
Covid 19 with cvs complications
 
Novel corona virus (COVID-19) its cause, symptoms and treatment
Novel corona virus (COVID-19) its cause, symptoms and treatmentNovel corona virus (COVID-19) its cause, symptoms and treatment
Novel corona virus (COVID-19) its cause, symptoms and treatment
 
MOLECULAR TOOLS IN DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES
MOLECULAR TOOLS IN  DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES MOLECULAR TOOLS IN  DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES
MOLECULAR TOOLS IN DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES
 

Similar to Understanding COVID-19 Variants and Vaccines

Coronavirus Pandemic Part III (B): Therapeutic Options
Coronavirus Pandemic Part III (B): Therapeutic OptionsCoronavirus Pandemic Part III (B): Therapeutic Options
Coronavirus Pandemic Part III (B): Therapeutic OptionsKumaraguru Veerasamy
 
Manufacturing the COVID-19 Pandemic Vaccine - Group 2
Manufacturing the COVID-19 Pandemic Vaccine - Group 2Manufacturing the COVID-19 Pandemic Vaccine - Group 2
Manufacturing the COVID-19 Pandemic Vaccine - Group 2KuchealArivalagan
 
Prospects and Problems of Development of Candidate Vaccine against COVID 19
Prospects and Problems of Development of Candidate Vaccine against COVID 19Prospects and Problems of Development of Candidate Vaccine against COVID 19
Prospects and Problems of Development of Candidate Vaccine against COVID 19ijtsrd
 
SUBTOPIC: COVID-19 vaccine action
SUBTOPIC: COVID-19 vaccine actionSUBTOPIC: COVID-19 vaccine action
SUBTOPIC: COVID-19 vaccine actionGagan Sharma
 
mRNA Vaccines and HIV
mRNA Vaccines and HIVmRNA Vaccines and HIV
mRNA Vaccines and HIVDhritisdiary
 
Coronavirus Pandemic Part III (C): Vaccines (rev01)
Coronavirus Pandemic Part III (C): Vaccines (rev01)Coronavirus Pandemic Part III (C): Vaccines (rev01)
Coronavirus Pandemic Part III (C): Vaccines (rev01)Kumaraguru Veerasamy
 
Covid-19 vaccine development
Covid-19 vaccine developmentCovid-19 vaccine development
Covid-19 vaccine developmentRachelMackelprang
 
疫苗研發之產學研合作經驗分享 以冠狀病毒奈米疫苗為例
疫苗研發之產學研合作經驗分享以冠狀病毒奈米疫苗為例疫苗研發之產學研合作經驗分享以冠狀病毒奈米疫苗為例
疫苗研發之產學研合作經驗分享 以冠狀病毒奈米疫苗為例hprc_tmu
 
Vaccines updates1
Vaccines updates1Vaccines updates1
Vaccines updates1imaging_70
 
subtopic of COVID- 19 VACCINE DEVELOPMENT AND TYPES
 subtopic of COVID- 19 VACCINE DEVELOPMENT AND TYPES subtopic of COVID- 19 VACCINE DEVELOPMENT AND TYPES
subtopic of COVID- 19 VACCINE DEVELOPMENT AND TYPESGagan Sharma
 
All you (never) wanted to know about COVID-19 and SARS-CoV-2
All you (never) wanted to know about COVID-19 and SARS-CoV-2All you (never) wanted to know about COVID-19 and SARS-CoV-2
All you (never) wanted to know about COVID-19 and SARS-CoV-2Edward Rybicki
 
Vaccines ingles - extendido
Vaccines   ingles - extendidoVaccines   ingles - extendido
Vaccines ingles - extendidomarinatesone
 
Cheryl Davis PowerPoint Presentation.pptx
Cheryl Davis PowerPoint Presentation.pptxCheryl Davis PowerPoint Presentation.pptx
Cheryl Davis PowerPoint Presentation.pptxWeldonFultz1
 
Plant transformation vectors and their types
Plant transformation vectors and their typesPlant transformation vectors and their types
Plant transformation vectors and their typesZahra Naz
 
2021 06-15-children-and-covid-19-vaccines-full-guide -final
2021 06-15-children-and-covid-19-vaccines-full-guide -final2021 06-15-children-and-covid-19-vaccines-full-guide -final
2021 06-15-children-and-covid-19-vaccines-full-guide -finalPhil Primeau
 

Similar to Understanding COVID-19 Variants and Vaccines (20)

Arntzen
ArntzenArntzen
Arntzen
 
Coronavirus Pandemic Part III (B): Therapeutic Options
Coronavirus Pandemic Part III (B): Therapeutic OptionsCoronavirus Pandemic Part III (B): Therapeutic Options
Coronavirus Pandemic Part III (B): Therapeutic Options
 
Manufacturing the COVID-19 Pandemic Vaccine - Group 2
Manufacturing the COVID-19 Pandemic Vaccine - Group 2Manufacturing the COVID-19 Pandemic Vaccine - Group 2
Manufacturing the COVID-19 Pandemic Vaccine - Group 2
 
Prospects and Problems of Development of Candidate Vaccine against COVID 19
Prospects and Problems of Development of Candidate Vaccine against COVID 19Prospects and Problems of Development of Candidate Vaccine against COVID 19
Prospects and Problems of Development of Candidate Vaccine against COVID 19
 
SUBTOPIC: COVID-19 vaccine action
SUBTOPIC: COVID-19 vaccine actionSUBTOPIC: COVID-19 vaccine action
SUBTOPIC: COVID-19 vaccine action
 
Vaccine Development in Global Pandemic (COVID-19)
Vaccine Development in Global Pandemic (COVID-19)Vaccine Development in Global Pandemic (COVID-19)
Vaccine Development in Global Pandemic (COVID-19)
 
mRNA Vaccines and HIV
mRNA Vaccines and HIVmRNA Vaccines and HIV
mRNA Vaccines and HIV
 
Coronavirus Pandemic Part III (C): Vaccines (rev01)
Coronavirus Pandemic Part III (C): Vaccines (rev01)Coronavirus Pandemic Part III (C): Vaccines (rev01)
Coronavirus Pandemic Part III (C): Vaccines (rev01)
 
2009 DEADLY VACCINE DEVELOPMENT
2009 DEADLY VACCINE DEVELOPMENT2009 DEADLY VACCINE DEVELOPMENT
2009 DEADLY VACCINE DEVELOPMENT
 
Covid-19 vaccine development
Covid-19 vaccine developmentCovid-19 vaccine development
Covid-19 vaccine development
 
疫苗研發之產學研合作經驗分享 以冠狀病毒奈米疫苗為例
疫苗研發之產學研合作經驗分享以冠狀病毒奈米疫苗為例疫苗研發之產學研合作經驗分享以冠狀病毒奈米疫苗為例
疫苗研發之產學研合作經驗分享 以冠狀病毒奈米疫苗為例
 
Vaccines updates1
Vaccines updates1Vaccines updates1
Vaccines updates1
 
subtopic of COVID- 19 VACCINE DEVELOPMENT AND TYPES
 subtopic of COVID- 19 VACCINE DEVELOPMENT AND TYPES subtopic of COVID- 19 VACCINE DEVELOPMENT AND TYPES
subtopic of COVID- 19 VACCINE DEVELOPMENT AND TYPES
 
All you (never) wanted to know about COVID-19 and SARS-CoV-2
All you (never) wanted to know about COVID-19 and SARS-CoV-2All you (never) wanted to know about COVID-19 and SARS-CoV-2
All you (never) wanted to know about COVID-19 and SARS-CoV-2
 
HIV and AIDS /prosthodontic courses
HIV and AIDS /prosthodontic coursesHIV and AIDS /prosthodontic courses
HIV and AIDS /prosthodontic courses
 
Vaccines ingles - extendido
Vaccines   ingles - extendidoVaccines   ingles - extendido
Vaccines ingles - extendido
 
Cheryl Davis PowerPoint Presentation.pptx
Cheryl Davis PowerPoint Presentation.pptxCheryl Davis PowerPoint Presentation.pptx
Cheryl Davis PowerPoint Presentation.pptx
 
Plant transformation vectors and their types
Plant transformation vectors and their typesPlant transformation vectors and their types
Plant transformation vectors and their types
 
2021 06-15-children-and-covid-19-vaccines-full-guide -final
2021 06-15-children-and-covid-19-vaccines-full-guide -final2021 06-15-children-and-covid-19-vaccines-full-guide -final
2021 06-15-children-and-covid-19-vaccines-full-guide -final
 
Covid-19 vaccines
Covid-19 vaccinesCovid-19 vaccines
Covid-19 vaccines
 

More from Varsha Khodiyar

Digital transformation to enable a FAIR approach for health data science
Digital transformation to enable a FAIR approach for health data scienceDigital transformation to enable a FAIR approach for health data science
Digital transformation to enable a FAIR approach for health data scienceVarsha Khodiyar
 
Lessons from the UK: Data access, patient trust & real-world impact with heal...
Lessons from the UK: Data access, patient trust & real-world impact with heal...Lessons from the UK: Data access, patient trust & real-world impact with heal...
Lessons from the UK: Data access, patient trust & real-world impact with heal...Varsha Khodiyar
 
COVID-19 variants, vaccines and tests
COVID-19 variants, vaccines and testsCOVID-19 variants, vaccines and tests
COVID-19 variants, vaccines and testsVarsha Khodiyar
 
Data citation and sharing during article publication
Data citation and sharing during article publicationData citation and sharing during article publication
Data citation and sharing during article publicationVarsha Khodiyar
 
The importance of research data repositories
The importance of research data repositoriesThe importance of research data repositories
The importance of research data repositoriesVarsha Khodiyar
 
What role can publishers play in the open data ecosystem?
What role can publishers play in the open data ecosystem?What role can publishers play in the open data ecosystem?
What role can publishers play in the open data ecosystem?Varsha Khodiyar
 
Five essentials factors for unlocking the potential for Open Research Data
Five essentials factors for unlocking the potential for Open Research Data Five essentials factors for unlocking the potential for Open Research Data
Five essentials factors for unlocking the potential for Open Research Data Varsha Khodiyar
 
New approaches to data management: supporting FAIR data sharing at Springer N...
New approaches to data management: supporting FAIR data sharing at Springer N...New approaches to data management: supporting FAIR data sharing at Springer N...
New approaches to data management: supporting FAIR data sharing at Springer N...Varsha Khodiyar
 
The value of data curation as part of the publishing process
The value of data curation as part of the publishing processThe value of data curation as part of the publishing process
The value of data curation as part of the publishing processVarsha Khodiyar
 
Preparing your data for sharing and publishing
Preparing your data for sharing and publishingPreparing your data for sharing and publishing
Preparing your data for sharing and publishingVarsha Khodiyar
 
Facilitating good research data management practice as part of scholarly publ...
Facilitating good research data management practice as part of scholarly publ...Facilitating good research data management practice as part of scholarly publ...
Facilitating good research data management practice as part of scholarly publ...Varsha Khodiyar
 
Practical challenges for researchers in data sharing
Practical challenges for researchers in data sharingPractical challenges for researchers in data sharing
Practical challenges for researchers in data sharingVarsha Khodiyar
 
Update from Data policy standardisation and implementation IG
Update from Data policy standardisation and implementation IGUpdate from Data policy standardisation and implementation IG
Update from Data policy standardisation and implementation IGVarsha Khodiyar
 
The challenge of sharing data well, how publishers can help
The challenge of sharing data well, how publishers can helpThe challenge of sharing data well, how publishers can help
The challenge of sharing data well, how publishers can helpVarsha Khodiyar
 
Data peer review workshop
Data peer review workshopData peer review workshop
Data peer review workshopVarsha Khodiyar
 
Peer Reviewing Data: experiences from a data journal
Peer Reviewing Data: experiences from a data journalPeer Reviewing Data: experiences from a data journal
Peer Reviewing Data: experiences from a data journalVarsha Khodiyar
 
Data Publishing and Institutional Repositories
Data Publishing and Institutional RepositoriesData Publishing and Institutional Repositories
Data Publishing and Institutional RepositoriesVarsha Khodiyar
 
Gaining credit for sharing research data
Gaining credit for sharing research dataGaining credit for sharing research data
Gaining credit for sharing research dataVarsha Khodiyar
 
Data sharing as part of the research workflow
Data sharing as part of the research workflowData sharing as part of the research workflow
Data sharing as part of the research workflowVarsha Khodiyar
 
Data sharing as part of the research ecosystem
Data sharing as part of the research ecosystemData sharing as part of the research ecosystem
Data sharing as part of the research ecosystemVarsha Khodiyar
 

More from Varsha Khodiyar (20)

Digital transformation to enable a FAIR approach for health data science
Digital transformation to enable a FAIR approach for health data scienceDigital transformation to enable a FAIR approach for health data science
Digital transformation to enable a FAIR approach for health data science
 
Lessons from the UK: Data access, patient trust & real-world impact with heal...
Lessons from the UK: Data access, patient trust & real-world impact with heal...Lessons from the UK: Data access, patient trust & real-world impact with heal...
Lessons from the UK: Data access, patient trust & real-world impact with heal...
 
COVID-19 variants, vaccines and tests
COVID-19 variants, vaccines and testsCOVID-19 variants, vaccines and tests
COVID-19 variants, vaccines and tests
 
Data citation and sharing during article publication
Data citation and sharing during article publicationData citation and sharing during article publication
Data citation and sharing during article publication
 
The importance of research data repositories
The importance of research data repositoriesThe importance of research data repositories
The importance of research data repositories
 
What role can publishers play in the open data ecosystem?
What role can publishers play in the open data ecosystem?What role can publishers play in the open data ecosystem?
What role can publishers play in the open data ecosystem?
 
Five essentials factors for unlocking the potential for Open Research Data
Five essentials factors for unlocking the potential for Open Research Data Five essentials factors for unlocking the potential for Open Research Data
Five essentials factors for unlocking the potential for Open Research Data
 
New approaches to data management: supporting FAIR data sharing at Springer N...
New approaches to data management: supporting FAIR data sharing at Springer N...New approaches to data management: supporting FAIR data sharing at Springer N...
New approaches to data management: supporting FAIR data sharing at Springer N...
 
The value of data curation as part of the publishing process
The value of data curation as part of the publishing processThe value of data curation as part of the publishing process
The value of data curation as part of the publishing process
 
Preparing your data for sharing and publishing
Preparing your data for sharing and publishingPreparing your data for sharing and publishing
Preparing your data for sharing and publishing
 
Facilitating good research data management practice as part of scholarly publ...
Facilitating good research data management practice as part of scholarly publ...Facilitating good research data management practice as part of scholarly publ...
Facilitating good research data management practice as part of scholarly publ...
 
Practical challenges for researchers in data sharing
Practical challenges for researchers in data sharingPractical challenges for researchers in data sharing
Practical challenges for researchers in data sharing
 
Update from Data policy standardisation and implementation IG
Update from Data policy standardisation and implementation IGUpdate from Data policy standardisation and implementation IG
Update from Data policy standardisation and implementation IG
 
The challenge of sharing data well, how publishers can help
The challenge of sharing data well, how publishers can helpThe challenge of sharing data well, how publishers can help
The challenge of sharing data well, how publishers can help
 
Data peer review workshop
Data peer review workshopData peer review workshop
Data peer review workshop
 
Peer Reviewing Data: experiences from a data journal
Peer Reviewing Data: experiences from a data journalPeer Reviewing Data: experiences from a data journal
Peer Reviewing Data: experiences from a data journal
 
Data Publishing and Institutional Repositories
Data Publishing and Institutional RepositoriesData Publishing and Institutional Repositories
Data Publishing and Institutional Repositories
 
Gaining credit for sharing research data
Gaining credit for sharing research dataGaining credit for sharing research data
Gaining credit for sharing research data
 
Data sharing as part of the research workflow
Data sharing as part of the research workflowData sharing as part of the research workflow
Data sharing as part of the research workflow
 
Data sharing as part of the research ecosystem
Data sharing as part of the research ecosystemData sharing as part of the research ecosystem
Data sharing as part of the research ecosystem
 

Recently uploaded

Cultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxCultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxpradhanghanshyam7136
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxgindu3009
 
Types of different blotting techniques.pptx
Types of different blotting techniques.pptxTypes of different blotting techniques.pptx
Types of different blotting techniques.pptxkhadijarafiq2012
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...RohitNehra6
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhousejana861314
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoSérgio Sacani
 
Caco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionCaco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionPriyansha Singh
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsSérgio Sacani
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfmuntazimhurra
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxAArockiyaNisha
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...jana861314
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSarthak Sekhar Mondal
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxkessiyaTpeter
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
 
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡anilsa9823
 
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |aasikanpl
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 

Recently uploaded (20)

Cultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxCultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptx
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptx
 
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
 
Types of different blotting techniques.pptx
Types of different blotting techniques.pptxTypes of different blotting techniques.pptx
Types of different blotting techniques.pptx
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhouse
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on Io
 
Caco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionCaco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorption
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdf
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
 
CELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdfCELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdf
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
 
The Philosophy of Science
The Philosophy of ScienceThe Philosophy of Science
The Philosophy of Science
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
 
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 

Understanding COVID-19 Variants and Vaccines

  • 1. COVID-19 variants and vaccines Varsha Khodiyar, PhD
  • 2. What is a virus?
  • 3. Key virus facts Source:https://www.open.edu/openlearn/science-maths-technology/biology/what-virus ● Genetic information (DNA or RNA) surrounded by protein ● Different shapes and sizes, typically 20–300 nm ● Cannot reproduce independently, needs a host cell ● Can survive for only short periods outside a host cell
  • 4. The SARS-CoV-2 virus which causes the disease COVID-19 Image source: https://www.nsf.gov/discoveries/disc_summ.jsp?cntn_id=300334&org=NSF
  • 5. Our cells also have RNA Image source: https://giphy.com/gifs/biology-primer-mRI1hW0ZBVUly Image source: https://www.ajconsultingcompany.com/cells_and_dna.html
  • 6. What does the virus RNA do in our cells? Image adapted from: https://courses.lumenlearning.com/boundless-biology/chapter/virus-infections-and-hosts/ SARS-CoV-2 attaches to human cell using the spike protein SARS-CoV-2 virus Human cell
  • 7. ● DNA and RNA are types of genetic material ● RNA is a naturally occurring part of our cells
  • 8. How do new virus strains evolve?
  • 9. Changes to DNA or RNA can alter protein sequence Image from: https://medlineplus.gov/genetics/understanding/mutationsanddisorders/possiblemutations/
  • 10. Genetic material is routinely damaged,but usually repaired Image adapted from: https://www.env.go.jp/en/chemi/rhm/basic-info/1st/03-02-03.html Change caused by chance or by environment (e.g. smoking)
  • 11. RNA viruses do not have the same type of repair mechanism and so are more likely to accumulate changes (mutations) Image source: Proc Natl Acad Sci U S A 2010 doi: 10.1073/pnas.0906193106
  • 12. Most changes will make the protein worse at doing its job... Image from: https://medlineplus.gov/genetics/understanding/mutationsanddisorders/possiblemutations/ ...but by chance some changes may make the protein better at doing its job
  • 13. Lots of changes results in new virus variants Source: https://www.bbc.co.uk/news/health-55659820
  • 14. ● Changes to the genetic code (mutations) happen all the time ● Most changes will make a protein less effective ● Multiple changes can result in the evolution of a new virus variant
  • 15. What do we know about the new SARS-CoV-2 strains?
  • 16. Research into SARS-CoV-2 and COVID-19 is ongoing
  • 17. What we know so far Sources: https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant.html ; https://www.bbc.co.uk/news/health-55659820 Identified variants are more transmissible, i.e. easier to catch Masks & social distancing work against these new variants All variants recognized by existing vaccines
  • 18. How do the coronavirus vaccines work? Sources: https://wellcome.org/news/what-different-types-covid-19-vaccine-are-there https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-vaccine/ Currently approved in the UK Viral vector vaccine: Oxford-AstraZeneca RNA vaccines: Pfizer-BioNTech, Moderna Use the cell’s own protein making machinery to make the virus protein The viral protein triggers an immune response The vaccines can be modified to recognise the new strains
  • 19. More about vaccines Source: https://wellcome.org/news/what-different-types-covid-19-vaccine-are-there
  • 21. What do we mean by‘vaccine efficacy’? Hypothetical efficacy of 80% 80 people in clinical trial protected against disease 20 people in clinical trial did not gain protection against disease Image adapted from: https://www.bmj.com/content/369/bmj.m1808 Reported efficacy against original covid-19 strain Oxford-AstraZeneca - 84% Pfizer-BioNTech - 95% Moderna - 92% Source: https://www.who.int/
  • 22. Poll -What is the effectiveness of the yearly flu vaccine? 0-20% 20-40% 40-60% 60-80% Over 80% Flu vaccine image from www.shutterstock.com
  • 23. 40-60% Effectiveness of the yearly influenza vaccines (Reduction in risk of having to go to the doctor with flu) Source: https://www.cdc.gov/flu/vaccines-work/effectiveness-studies.htm
  • 24. SARS-CoV-2 will mutate every time it replicates We can reduce the chance for new strains to evolve by reducing the opportunities for the virus to reproduce
  • 25. COVID-19 is likely to become endemic Source: https://www.nature.com/articles/d41586-021-00396-2
  • 26. Finding out more Image source: https://mrbarlow.wordpress.com/2012/11/24/take-breaks-to-learn-more/
  • 27. Use reputable news sources for latest information Information sources I find useful: BBC news website BBC, ITV and Channel 4 TV news programmes (radio & TV) USA CDC website (https://www.cdc.gov/coronavirus/2019-ncov/variants/index.html) Nature news features (https://www.nature.com/nature/articles?type=news-feature) How can you tell if the information is accurate? Check multiple sources
  • 28. Debunking coronavirus myths -www.covidfaq.co
  • 29. What is the difference between fact and opinion? A fact is true, whether or not you believe it Can be proved to be correct with evidence. An opinion is what someone thinks or believes. Cannot be proved to be correct or incorrect. Source: https://www.bbc.co.uk/teach/skillswise/fact-or-opinion/z4r7cqt
  • 30. Check that your information sources are reputable and worthy of your trust
  • 31. “Knowledge is power” Sir Francis Bacon (1597)
  • 32. @varsha_khodiyar Varsha Khodiyar The information in this slide deck was presented at the Asha-Deep Project webinar Thursday 18th February 2021 Asha-Deep Project email: ashadeepc19@gmail.com Slide deck created by Varsha Khodiyar Slide deck licensed as CC-BY https://creativecommons.org/licenses/by/4.0/